Pneumocystis in metastatic lung cancer, a pragmatic approach in support of prophylaxis - Université de Rennes Accéder directement au contenu
Article Dans Une Revue BMJ Case Reports Année : 2021

Pneumocystis in metastatic lung cancer, a pragmatic approach in support of prophylaxis

Résumé

Lung cancer prognosis has improved in the last decade, including in patients with brain metastasis. However, few of these patients who receive corticosteroids have a primary prophylaxis for pneumonia (PJP). We report the case of an 80-year-old man diagnosed with non-small cell lung cancer and concomitant symptomatic brain metastases, treated with 50 mg/day of prednisolone without any prophylaxis, who presented an acute PJP. After 72 hours of unsuccessful treatment of PJP, the patient died. In our review of this case and the existing literature, we emphasise the importance of a wide use of prophylaxis for PJP, especially in advanced lung cancer treated with corticosteroid therapy. We discuss this issue and report current evidence for primary prophylaxis by trimethoprim-sulfamethoxazole.
Fichier principal
Vignette du fichier
e232895.full.pdf (424.23 Ko) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-03372959 , version 1 (30-05-2022)

Licence

Paternité - Pas d'utilisation commerciale

Identifiants

Citer

David Luque Paz, Stephane Jouneau, Pierre Tattevin, Charles Ricordel. Pneumocystis in metastatic lung cancer, a pragmatic approach in support of prophylaxis. BMJ Case Reports, 2021, 14 (6), pp.e232895. ⟨10.1136/bcr-2019-232895⟩. ⟨hal-03372959⟩
24 Consultations
17 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More